AI assistant
Vericel Corp — Director's Dealing 2022
Feb 22, 2022
31799_dirs_2022-02-22_daa6eaa9-cbc7-4706-b00e-f8f287ffcb58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2022-02-18
Reporting Person: Mara Joseph Anthony Jr (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-18 | Restricted Stock Unit | $ | A | 11018 | Acquired | Common Stock (11018) | Direct | |
| 2022-02-18 | Stock Option (right to buy) | $34.90 | A | 2865 | Acquired | 2032-02-18 | Common Stock (2865) | Direct |
| 2022-02-18 | Stock Option (right to buy) | $34.90 | A | 61404 | Acquired | 2032-02-18 | Common Stock (61404) | Direct |
Footnotes
F1: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F2: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.
F3: No expiration date for this type of award.
F4: These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.